VolitionRx Limited Schedules First Quarter 2017 Earnings Conference Call and Business Update
Volition makes progress with its Colorectal Cancer Screening Triage Test in both Asia and Europe
Volition opens a new Research and Development facility in Belgium with a state of the art, purpose-built laboratory
VolitionRx Appoints David Vanston as Chief Financial Officer
Volition America, Inc. Retains Strategic Expert in Securing Non-Dilutive Funding Opportunities in the United States
VolitionRx Limited Announces the Formation of Volition America, Inc.
VolitionRx Limited Celebrates CE Mark Announcement By Ringing Closing Bell at the New York Stock Exchange
VolitionRx Limited to Ring the New York Stock Exchange Closing Bell on Monday, March 13th at 4 pm Eastern Daylight Time
VolitionRx Limited Announces Full Fiscal Year 2016 Financial Results and Business Update
VolitionRx Limited to Present at the 29th Annual ROTH Conference
